CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 450 target
Drug / intervention
Escitalopram +1 moredrug
Likely dose
Escitalopram 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00300313
NCT00300313N/ACompleted
CompareCT.gov

PTSD Prevention Using Escitalopram

Sheba Medical Center·interventional·Posted Mar 8, 2006·Updated Dec 31, 2013

In Brief

A clinical study evaluating Escitalopram and Placebo for Post-traumatic Stress Disorder. Completed, enrolled 450 participants across 5 sites.

Detailed Summary

Assessing the efficacy of escitalopram in preventing the development of PTSD, or or reducing its severeness, after exposure to a traumatic event.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-traumatic Stress Disorder
CountriesIsrael
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 8, 2006
Enrollment StartJun 1, 2005
Primary CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 20.3 years ago

Interventions

Escitalopramdrug

10 to 20 mg / day

Placebodrug

1-2 capsules